Cansenseltd

Developer of blood test technology for early detection of bowel cancer

placeSwansea, Wales, United Kingdom groups1 employees language cansenseltd.com

Social engagement

Social engagement: 1.7K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Mercia, Development Bank of Wales, Nonacus.

Investor typeCountShare
Private equity125%
Other / undisclosed375%

Recent activity

30 Jun 2026
Partnership
HealthX Connect Osaka and WHX Osaka
Coming soon